Genesis Axis Acquires Organochem to Grow the Preclinical Chemistry Services Portfolio
/PRNewswire/ -- Genesis Axis that manages the international Contract Research Organization (CRO) arm of Genesis Drug Discovery and Development™ (GD3),...
Source: prnewswire.com